CA3158175A1 - Benzothiazepine compounds and their use as bile acid modulators - Google Patents
Benzothiazepine compounds and their use as bile acid modulators Download PDFInfo
- Publication number
- CA3158175A1 CA3158175A1 CA3158175A CA3158175A CA3158175A1 CA 3158175 A1 CA3158175 A1 CA 3158175A1 CA 3158175 A CA3158175 A CA 3158175A CA 3158175 A CA3158175 A CA 3158175A CA 3158175 A1 CA3158175 A1 CA 3158175A1
- Authority
- CA
- Canada
- Prior art keywords
- amino acid
- acid position
- tetrahydro
- benzothiazepin
- dioxido
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D281/02—Seven-membered rings
- C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D281/10—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201911049985 | 2019-12-04 | ||
| IN201911049985 | 2019-12-04 | ||
| PCT/EP2020/084571 WO2021110887A1 (en) | 2019-12-04 | 2020-12-04 | Benzothiazepine compounds and their use as bile acid modulators |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3158175A1 true CA3158175A1 (en) | 2021-06-10 |
Family
ID=82196618
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3158175A Pending CA3158175A1 (en) | 2019-12-04 | 2020-12-04 | Benzothiazepine compounds and their use as bile acid modulators |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP4069362A1 (https=) |
| JP (1) | JP7665621B2 (https=) |
| CN (1) | CN114786773B (https=) |
| CA (1) | CA3158175A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4188541B1 (en) * | 2020-08-03 | 2024-12-25 | Albireo AB | Benzothia(di)azepine compounds and their use as bile acid modulators |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9800428D0 (en) * | 1998-01-10 | 1998-03-04 | Glaxo Group Ltd | Chemical compounds |
| EG26979A (en) * | 2000-12-21 | 2015-03-01 | Astrazeneca Ab | Chemical compounds |
| GB0121337D0 (en) * | 2001-09-04 | 2001-10-24 | Astrazeneca Ab | Chemical compounds |
| JP6097695B2 (ja) * | 2010-11-08 | 2017-03-15 | アルビレオ アクチエボラグ | Ibat阻害剤および胆汁酸結合剤を含む薬学的組み合わせ |
-
2020
- 2020-12-04 CA CA3158175A patent/CA3158175A1/en active Pending
- 2020-12-04 EP EP20821144.1A patent/EP4069362A1/en active Pending
- 2020-12-04 JP JP2022532833A patent/JP7665621B2/ja active Active
- 2020-12-04 CN CN202080083824.3A patent/CN114786773B/zh active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP4069362A1 (en) | 2022-10-12 |
| CN114786773B (zh) | 2024-10-18 |
| JP2023504646A (ja) | 2023-02-06 |
| CN114786773A (zh) | 2022-07-22 |
| JP7665621B2 (ja) | 2025-04-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12187690B2 (en) | Benzothiadiazepine compounds and their use as bile acid modulators | |
| US12024495B2 (en) | Benzothiazepine compounds and their use as bile acid modulators | |
| TWI877262B (zh) | 苯并噻氮呯化合物及其作為膽酸調節劑之用途 | |
| US11708340B2 (en) | Benzothia(di)azepine compounds and their use as bile acid modulators | |
| US20250019353A1 (en) | Benzothia(di)azepine compounds and their use as bile acid modulators | |
| EP4069247B1 (en) | Benzothiadiazepine compounds and their use as bile acid modulators | |
| US11603359B2 (en) | Benzothiadiazepine compounds and their use as bile acid modulators | |
| CA3218474A1 (en) | Benzothia(di)azepine compounds and their use as bile acid modulators | |
| WO2021110885A1 (en) | Benzothiadiazepine compounds and their use as bile acid modulators | |
| CA3127408A1 (en) | Benzothiazepine compounds and their use as bile acid modulators | |
| CA3158181A1 (en) | Benzothia(di)azepine compounds and their use as bile acid modulators | |
| CA3186857A1 (en) | Benzothia(di)azepine compounds and their use as bile acid modulators | |
| US20240067617A1 (en) | Benzothia(di)azepine compounds and their use as bile acid modulators | |
| CA3158175A1 (en) | Benzothiazepine compounds and their use as bile acid modulators | |
| HK40082184A (en) | Benzothiadiazepine compounds and their use as bile acid modulators | |
| HK40082184B (en) | Benzothiadiazepine compounds and their use as bile acid modulators | |
| HK40082185A (en) | Benzothia(di)azepine compounds and their use as bile acid modulators | |
| HK40065832B (en) | Benzothiadiazepine compounds and their use as bile acid modulators | |
| HK40065832A (en) | Benzothiadiazepine compounds and their use as bile acid modulators |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 4TH ANNIV.) - STANDARD Year of fee payment: 4 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20241119 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT Effective date: 20241119 Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20241119 |
|
| D11 | Substantive examination requested |
Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D11-D117 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION RECEIVED Effective date: 20241203 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P11-P101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - VOLUNTARY AMENDMENT Effective date: 20241203 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20241204 |
|
| D00 | Search and/or examination requested or commenced |
Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D00-D118 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION REQUIREMENTS DETERMINED COMPLIANT Effective date: 20250102 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT Effective date: 20250102 |
|
| P13 | Application amended |
Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED Effective date: 20250102 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20250102 |
|
| D11 | Substantive examination requested |
Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D11-D155 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: ALL REQUIREMENTS FOR EXAMINATION DETERMINED COMPLIANT Effective date: 20250507 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20250523 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 5TH ANNIV.) - STANDARD Year of fee payment: 5 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20251014 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20251014 |
|
| D15 | Examination report completed |
Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D15-D126 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: EXAMINER'S REPORT Effective date: 20260120 |